Find the right fit for you - faster
Get tailored insights about working at UCB in one quick step.
UCB Snapshot
Our vision
UCB’s ambition is to transform the lives of people living with severe diseases, allowing them to live the best life that they can – as free as possible from the challenges and uncertainty of disease. That commitment comes to life in our research and development activities across neurology, immunology and other areas where our expertise, innovation and ambition align with unmet needs.
UCB is continuously working to advance science and embrace new knowledge, bringing passion and leadership to solving the challenges that matter to people living with severe diseases. We are leveraging scientific advances and new technologies in areas including genetics, biomarkers and human biology. Continually inspired by those we serve to bring differentiated solutions with unique outcomes that deliver tangible, positive impacts.
UCB’s ambition is to transform the lives of people living with severe diseases, allowing them to live the best life that they can – as free as possible from the challenges and uncertainty of disease. That commitment comes to life in our research and development activities across neurology, immunology and other areas where our expertise, innovation and ambition align with unmet needs.
UCB is continuously working to advance science and embrace new knowledge, bringing passion and leadership to solving the challenges that matter to people living with severe diseases. We are leveraging scientific advances and new technologies in areas including genetics, biomarkers and human biology. Continually inspired by those we serve to bring differentiated solutions with unique outcomes that deliver tangible, positive impacts.
UCB – Inspired by patients. Driven by science.
At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We're here because we want to transform patients’ lives by pushing the boundaries of what is possible.
To achieve our ambition, we welcome talented individuals with diverse backgrounds and experiences - not just the brightest minds, but those who truly care about making a meaningful difference.
With a team of approximately 7,500 employees and operations in more than 40 countries, we are a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
UCB – The Facts
• 7500 people in 40 countries, with over 70 nationalities
• 49% women, 51% men
• ~25% of revenue invested in R&D
• Total revenue grew to €4.9 billion in 2019
At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We're here because we want to transform patients’ lives by pushing the boundaries of what is possible.
To achieve our ambition, we welcome talented individuals with diverse backgrounds and experiences - not just the brightest minds, but those who truly care about making a meaningful difference.
With a team of approximately 7,500 employees and operations in more than 40 countries, we are a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
UCB – The Facts
• 7500 people in 40 countries, with over 70 nationalities
• 49% women, 51% men
• ~25% of revenue invested in R&D
• Total revenue grew to €4.9 billion in 2019
